REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Contract Pharma Solutions (Lithuania)

Main Activities: Other Food Manufacturing | All Other Miscellaneous Food Manufacturing
Full name: UAB Contract Pharma Solutions Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Contract Pharma Solutions is a company in Lithuania, with a head office in Kaunas. It operates in the Other Food Manufacturing sector. The company was established on March 05, 2013. It currently has a total number of 41 (2025) employees. In 2024, the company reported a net sales revenue increase of 59.71%. The net profit margin of UAB Contract Pharma Solutions increased by 8.99% in 2024.

Headquarters
Garliava Bijunu g. 30
Kaunas; Kaunas County; Postal Code: LT-53267

Contact Details: Purchase the UAB Contract Pharma Solutions report to view the information.

Basic Information
Total Employees:
Purchase the UAB Contract Pharma Solutions report to view the information.
Registered Capital:
Purchase the UAB Contract Pharma Solutions report to view the information.
Financial Auditors:
Purchase the UAB Contract Pharma Solutions report to view the information.
Incorporation Date:
March 05, 2013
Key Executives
Purchase this report to view the information.
Member of the Management Board
Company Performance
Financial values in the chart are available after UAB Contract Pharma Solutions report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
59.71%
Total operating revenue
59.71%
Net Profit (Loss) for the Period
142.9%
Total Equity
86.85%
Net Profit Margin
8.99%
Return on Equity (ROE)
10.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?